Blog
Planify news
Sanofi India, Emcure Pharma announce exclusive distribution partnership
Link copied
Sanofi India, Emcure Pharma announce exclusive distribution partnership
18 March 2024
Sanofi India and Emcure Pharmaceuticals on Monday announced an exclusive distribution and promotion agreement for Sanofi’s cardiovascular products in India. Effective immediately, Emcure Pharmaceuticals will exclusively distribute and promote Sanofi India’s Cardiovascular brands including Cardace, Clexane, Targocid, Lasix, and Lasilactone.
Sanofi India and Emcure Pharmaceuticals on Monday announced an exclusive distribution and promotion agreement for Sanofi’s cardiovascular products in India. Effective immediately, Emcure Pharmaceuticals will exclusively distribute and promote Sanofi India’s Cardiovascular brands including Cardace, Clexane, Targocid, Lasix, and Lasilactone.
Stay Connected, Stay Informed –
Join Our
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.